Literature DB >> 30052567

Approach and Safety of Esophageal Dilation for Treatment of Strictures in Children With Epidermolysis Bullosa.

Bradley T Anderson1, James A Feinstein1,2, Robert E Kramer1,3, Michael R Narkewicz1,3, Anna L Bruckner1,4, David E Brumbaugh1,3.   

Abstract

OBJECTIVE: The aim of the study is to analyze a large series of esophageal balloon dilations in patients with epidermolysis bullosa (EB) to determine procedural approach and frequency of post-endoscopic adverse events (AEs).
METHODS: Retrospective chart review for AE occurrence and clinical outcomes in children and adolescents with EB, age 1 to 19, who underwent esophageal dilation for esophageal stricture(s) from January 2003 to April 2016 at an academic, tertiary care, free-standing children's hospital. The primary outcome measure was occurrence of procedural AEs (defined as events occurring within 72 hours after endoscopic dilation procedure).
RESULTS: A total of 231 fluoroscopy-guided esophageal balloon dilation procedures (209 anterograde, 20 retrograde, 2 both) were performed in 24 patients. Strictures were more common in the proximal portion of the esophagus with median stricture location 13 cm from the lips. From 2003 to 2012, 4.1% of dilations were retrograde. From 2013 to 2016, 20.2% of dilations were retrograde. AEs attributable to dilation occurred after 10.0% of procedures, and the most common AEs were vomiting, pain, and fever. No esophageal perforations, serious bleeding events, or deaths occurred secondary to dilation. The rate of post-dilation hospitalization was 6.9%. Dilation approach (anterograde vs retrograde) did not impact the likelihood of AEs.
CONCLUSIONS: The characteristic esophageal lesion in EB is a single, proximal esophageal stricture. EB patients can safely undergo repeat pneumatic esophageal balloon dilations with minimal risk for severe complication. We observed a trend towards increased use of retrograde esophageal dilation.

Entities:  

Mesh:

Year:  2018        PMID: 30052567      PMCID: PMC6249086          DOI: 10.1097/MPG.0000000000002106

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  23 in total

1.  Endoscopic dilatation of esophageal strictures in recessive dystrophic epidermolysis bullosa: new equipment, new techniques.

Authors:  Marsha Kay; Robert Wyllie
Journal:  J Pediatr Gastroenterol Nutr       Date:  2002-05       Impact factor: 2.839

2.  Gastrointestinal manifestations of epidermolysis bullosa. A study of 101 patients.

Authors:  G A Ergun; A N Lin; A J Dannenberg; D M Carter
Journal:  Medicine (Baltimore)       Date:  1992-05       Impact factor: 1.889

3.  Esophageal strictures in children with recessive dystrophic epidermolysis bullosa: an 11-year experience with fluoroscopically guided balloon dilatation.

Authors:  Richard G Azizkhan; Wolfgang Stehr; Aliza P Cohen; Eric Wittkugel; Michael K Farrell; Anne W Lucky; Benjamin D Hammelman; Neil D Johnson; John M Racadio
Journal:  J Pediatr Surg       Date:  2006-01       Impact factor: 2.545

4.  Endoscopic balloon dilatation of benign esophageal strictures in childhood: a 15-year experience.

Authors:  M Cakmak; O Boybeyi; G Gollu; G Kucuk; M Bingol-Kologlu; A Yagmurlu; T Aktug; H Dindar
Journal:  Dis Esophagus       Date:  2014-12-17       Impact factor: 3.429

Review 5.  Epidermolysis bullosa: management of esophageal strictures and enteric access by gastrostomy.

Authors:  Alan E Mortell; Richard G Azizkhan
Journal:  Dermatol Clin       Date:  2010-04       Impact factor: 3.478

6.  A two-step multidisciplinary approach to treat recurrent esophageal strictures in children with epidermolysis bullosa dystrophica.

Authors:  Thorsten Vowinkel; Mike Laukoetter; Rudolf Mennigen; Klaus Hahnenkamp; Antje Gottschalk; Matthias Boschin; Michael Frosch; Norbert Senninger; Dirk Tübergen
Journal:  Endoscopy       Date:  2015-01-15       Impact factor: 10.093

7.  Fluoroscopic balloon dilatation for caustic esophageal stricture in children: an 8-year experience.

Authors:  Ibrahim Uygun; Mehmet Serif Arslan; Bahattin Aydogdu; Mehmet Hanifi Okur; Selcuk Otcu
Journal:  J Pediatr Surg       Date:  2013-11       Impact factor: 2.545

8.  Management of esophageal stenosis in recessive dystrophic epidermolysis bullosa.

Authors:  G E Feurle; H Weidauer; G Baldauf; T Schulte-Braucks; I Anton-Lamprecht
Journal:  Gastroenterology       Date:  1984-12       Impact factor: 22.682

9.  Management of esophageal strictures in children with recessive dystrophic epidermolysis bullosa.

Authors:  Ricardo O Castillo; Yinka K Davies; Yuan-Chi Lin; Manuel Garcia; Harvey Young
Journal:  J Pediatr Gastroenterol Nutr       Date:  2002-05       Impact factor: 2.839

10.  Incidence and management of oesophageal ruptures following fluoroscopic balloon dilatation in children with benign strictures.

Authors:  Wei-Zhong Zhou; Ho-Young Song; Jung-Hoon Park; Ji Hoon Shin; Jin Hyoung Kim; Young Chul Cho; Pyeong Hwa Kim; Seong-Chul Kim
Journal:  Eur Radiol       Date:  2016-04-05       Impact factor: 5.315

View more
  2 in total

Review 1.  Emergency management in epidermolysis bullosa: consensus clinical recommendations from the European reference network for rare skin diseases.

Authors:  Jemima E Mellerio; Maya El Hachem; Nathalia Bellon; Giovanna Zambruno; Hana Buckova; Rudolf Autrata; Carmen Salavastru; Tamara Caldaro; Celine Greco; Cristina Has; Christine Bodemer
Journal:  Orphanet J Rare Dis       Date:  2020-06-06       Impact factor: 4.123

2.  Clinical practice guidelines: Oral health care for children and adults living with epidermolysis bullosa.

Authors:  Susanne Krämer; James Lucas; Francisca Gamboa; Miguel Peñarrocha Diago; David Peñarrocha Oltra; Marcelo Guzmán-Letelier; Sanchit Paul; Gustavo Molina; Lorena Sepúlveda; Ignacio Araya; Rubén Soto; Carolina Arriagada; Anne W Lucky; Jemima E Mellerio; Roger Cornwall; Fatimah Alsayer; Reinhard Schilke; Mark Adam Antal; Fernanda Castrillón; Camila Paredes; Maria Concepción Serrano; Victoria Clark
Journal:  Spec Care Dentist       Date:  2020-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.